A newly identified protein from HTLV-III/LAV, the virus implicated as the etiologic agent of the
acquired immune deficiency syndrome, was studied. This protein, which has a molecular …

Human T-lymphotropic virus type III (HTLV-III) or lymphadenopathy-associated virus (LAV) is
tropic for human T cells with the helper-inducer phenotype, as defined by reactivity with …

In this study, two glycoproteins (gp160 and gp120) that are encoded by human T-cell
lymphoma virus type III (HTLV-III) were the antigens most consistently recognized by …

The nucleotide sequence of the genome of HTLV-III, the infectious agent etiologically
associated with the acquired immune deficiency syndrome, predicts a small open reading …

Approximately 80 percent of all human sera that react with antigens of HTLV-III, the etiologic
agent of the acquired immune deficiency syndrome (AIDS), recognize protein bands at 66 …

Human T-cell lymphotropic retrovirus type III (HTLV-III), also called lymphadenopathy-
associated virus (LAV), has been identified as the aetiological agent of acquired immune …

Radiolabeled amino acid sequencing was used to characterize gp41, an antigen of HTLV-
III/LAV, the virus believed to be the etiological agent of the acquired immune deficiency …

Epidemiological results suggest that the etiological agent of the acquired immune deficiency
syndrome (AIDS) is transmitted primarily through blood products, semen, and saliva. There …

In cats, infection with T-lymphotropic retroviruses can cause T-cell proliferation and leukemia
or T-cell depletion and immunosuppression. In humans, some highly T4 tropic retroviruses …

Antibodies from the serum of patients with the acquired immune deficiency syndrome (AIDS)
or with the AIDS-related complex and from the serum of seropositive healthy homosexuals …